Benjamin Wolf

Compass (United States) — United States

Medicine · Health Sciences

17h-index1.2kcitations88works5.92yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Monoclonal and Polyclonal Antibodies Research(15), Cytokine Signaling Pathways and Interactions(13), interferon and immune responses(13), T-cell and B-cell Immunology(11), Glycosylation and Glycoproteins Research(11)

Publications87 total

Data from <i>TREX1</i> Inactivation Unleashes Cancer Cell STING–Interferon Signaling and Promotes Antitumor Immunity
2024· 1 citedOpen Access
Supplementary figure S3 from <i>TREX1</i> Inactivation Unleashes Cancer Cell STING–Interferon Signaling and Promotes Antitumor Immunity
2024Open Access
Supplementary figure S2 from <i>TREX1</i> Inactivation Unleashes Cancer Cell STING–Interferon Signaling and Promotes Antitumor Immunity
2024Open Access
Supplementary figure S4 from <i>TREX1</i> Inactivation Unleashes Cancer Cell STING–Interferon Signaling and Promotes Antitumor Immunity
2024Open Access
Supplementary Table S1 from <i>TREX1</i> Inactivation Unleashes Cancer Cell STING–Interferon Signaling and Promotes Antitumor Immunity
2024Open Access
Data from <i>TREX1</i> Inactivation Unleashes Cancer Cell STING–Interferon Signaling and Promotes Antitumor Immunity
2024Open Access
Supplementary figure S2 from <i>TREX1</i> Inactivation Unleashes Cancer Cell STING–Interferon Signaling and Promotes Antitumor Immunity
2024Open Access
Supplementary figure S1 from <i>TREX1</i> Inactivation Unleashes Cancer Cell STING–Interferon Signaling and Promotes Antitumor Immunity
2024Open Access
Supplementary figure S3 from <i>TREX1</i> Inactivation Unleashes Cancer Cell STING–Interferon Signaling and Promotes Antitumor Immunity
2024Open Access
Supplementary Table S1 from <i>TREX1</i> Inactivation Unleashes Cancer Cell STING–Interferon Signaling and Promotes Antitumor Immunity
2024Open Access
Supplementary figure S4 from <i>TREX1</i> Inactivation Unleashes Cancer Cell STING–Interferon Signaling and Promotes Antitumor Immunity
2024Open Access
Supplementary figure S1 from <i>TREX1</i> Inactivation Unleashes Cancer Cell STING–Interferon Signaling and Promotes Antitumor Immunity
2024Open Access
A bispecific anti-PD-1 and PD-L1 antibody induces PD-1 cleavage and provides enhanced anti-tumor activity
OncoImmunology·2024· 3 citedOpen Access
<i>TREX1</i> Inactivation Unleashes Cancer Cell STING–Interferon Signaling and Promotes Antitumor Immunity
Cancer Discovery·2024· 79 citedOpen Access
A WNT protein therapeutic accelerates consolidation of a bone graft substitute in a pre‐clinical sinus augmentation model
Journal Of Clinical Periodontology·2022· 4 cited
Biology of sinus floor augmentation with an autograft versus a bone graft substitute in a preclinical in vivo experimental model
Clinical Oral Implants Research·2021· 16 cited
Numb Chin in Sickle Cell Anemia During Pregnancy
Deutsches Ärzteblatt international·2020Open Access
164 AgenT-797, a novel allogenic and ‘off-the shelf’ iNKT cell therapy promotes effective tumor killing
Regular and Young Investigator Award Abstracts·2020· 2 citedOpen Access
Differentiated agonistic antibody targeting CD137 eradicates large tumors without hepatotoxicity
JCI Insight·2020· 45 citedOpen Access
N2O isotope research: development of reference materials and metrological characterization of OIRS analyzers within the SIRS project
2020Open Access
page 1 of 5Next →

Frequent Co-authors

Edward S. Kimball(6), Michael B. Brenner(5), Michael F. Princiotta(4), Raju V. V. Tatituri(3), D. Catty(3), Abram B. Stavitsky(3), Richard B. Bankert(3), Martin L. Yarmush(3), G Niebauer(2), Reza I. Bashey(2), Charles D. Newton(2), Lawrence R. Soma(2), William J. Donawick(2), Adam P. Uldrich(2), Jamie Rossjohn(2), Gurdyal S. Besra(2), Dale I. Godfrey(2), Xavier Michelet(2), R.R.A. Coombs(2), P. G. H. Gell(2)